Jincheng Pharm(SZ:300233) Xin Lang Cai Jing·2026-01-21 07:12Group 1 - The core viewpoint of the news is that Jincheng Pharmaceutical's stock has increased by 5.37%, reaching a price of 15.88 yuan per share, with a trading volume of 1.81 billion yuan and a turnover rate of 3.15%, resulting in a total market capitalization of 60.96 billion yuan [1] - Jincheng Pharmaceutical, established on January 12, 2004, and listed on June 22, 2011, is located in Zibo City, Shandong Province. The company specializes in the research, production, and sales of pharmaceutical intermediates, active pharmaceutical ingredients, and finished formulations [1] - The revenue composition of Jincheng Pharmaceutical includes: formulation products at 34.59%, other pharmaceutical and chemical products at 26.61%, cephalosporin side-chain active ester series products at 21.88%, and biopharmaceuticals and specialty active pharmaceutical ingredients at 16.92% [1] Group 2 - Among the top circulating shareholders of Jincheng Pharmaceutical, a fund under the Fortune Fund ranks as a significant stakeholder. The Fortune Precision Medical Flexible Allocation Mixed A Fund (005176) entered the top ten circulating shareholders in the third quarter, holding 4.961 million shares, which accounts for 1.33% of the circulating shares [2] - The Fortune Precision Medical Flexible Allocation Mixed A Fund has a current scale of 3.491 billion yuan, with a year-to-date return of 4.34%, ranking 4447 out of 8844 in its category. Over the past year, it has achieved a return of 40.91%, ranking 2780 out of 8091, and since its inception, it has returned 212.06% [2] Group 3 - The fund manager of the Fortune Precision Medical Flexible Allocation Mixed A Fund is Zhao Wei, who has been in the position for 8 years and 218 days. The total asset scale of the fund is 9.845 billion yuan, with the best return during his tenure being 190.69% and the worst return being -13.15% [3]